Identification of Dual Inhibitors Targeting Main Protease (M<sup>pro</sup>) and Cathepsin L as Potential Anti-SARS-CoV-2 Agents-Reference-Cited by-同舟云学术

Identification of Dual Inhibitors Targeting Main Protease (M^pro) and Cathepsin L as Potential Anti-SARS-CoV-2 Agents

Published:2024-03-01 Issue:5 Volume:15 Page:602-609
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Previti Santo¹^ORCID,Ettari Roberta¹^ORCID,Calcaterra Elsa¹,Roggia Michele²^ORCID,Natale Benito²^ORCID,Weldert Annabelle C.³^ORCID,Müller-Ruttloff Christin⁴,Salisch Florian⁴,Irto Anna¹,Cigala Rosalia Maria¹,Ziebuhr John⁴,Schirmeister Tanja³,Cosconati Sandro²^ORCID,Zappalà Maria¹^ORCID

Affiliation:

1. Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Stagno d’Alcontres 31, 98166 Messina, Italy

2. DiSTABiF, University of Campania Luigi Vanvitelli, Via Vivaldi 43, 81100 Caserta, Italy

3. Institute of Pharmaceutical and Biomedical Sciences, University of Mainz, 55128 Mainz, Germany

4. Institute of Medical Virology, Justus Liebig University Giessen, Schubertstr. 81, 35392, Giessen, Germany

Funder

Deutsche Forschungsgemeinschaft

Uniklinikum Giessen und Marburg

Ministero dell'Università e della Ricerca

Deutsches Zentrum für Infektionsforschung

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.3c00562

Reference43 articles.

1. Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects

2. Vaccines and therapeutics for immunocompromised patients with COVID-19

3. Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management

4. Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials

5. Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection